Tailored Intervention Fails to Improve CRC Screening Rates

Share this content:
Tailored Intervention Fails to Improve CRC Screening Rates
Tailored Intervention Fails to Improve CRC Screening Rates

(HealthDay News) -- An interactive multimedia computer program (IMCP) tailored to expanded health belief model sociopsychological factors is no more effective for encouraging colorectal cancer screening than a control nontailored informational program, according to a study published in the May/June issue of the Annals of Family Medicine.

Anthony Jerant, MD, from the University of California Davis School of Medicine in Sacramento, and colleagues conducted a randomized trial to examine whether an IMCP could promote colorectal cancer screening in a multiethnic sample. 

RELATED: Gastrointestinal Cancers Resource Center

A total of 1,164 patients were enrolled, stratified by ethnicity and language (49.3% non-Hispanic, 27.2% Hispanic/English, and 23.4% Hispanic/Spanish), and were randomly allocated to IMCP tailored to sociopsychological factors or a nontailored informational program.

The researchers found that, compared with control patients, IMCP correlated with significantly greater colorectal cancer screening knowledge, self-efficacy, readiness, test preference specificity, discussion, and recommendation, after adjustment for ethnicity/language, study center, and the previsit value of the dependent variable. 

Twenty-three percent of ICMP and 22% of control patients received screening during follow-up (difference, 0.5%; 95% confidence interval, −4.3 to 5.3). The effects of IMCP did not vary by ethnicity/language.

"Sociopsychological factor tailoring was no more effective than nontailored information in encouraging colorectal cancer screening in a multiethnic sample, despite enhancing sociopsychological factors and visit behaviors associated with screening," the researchers wrote.


  1. Jerant A, Kravitz RL, Sohler N, et al. Sociopsychological Tailoring to Address Colorectal Cancer Screening Disparities: A Randomized Controlled Trial. Ann Fam Med. 2014;12(3):204-214.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs